Prenatal Screening of Trisomy 21: Could Oxidative Stress Markers Play a Role?

Despite significant progress in trisomy 21 (T21) diagnostic tools, amniocentesis is still used for the confirmation of an abnormal fetal karyotype. Invasive tests carry the potential risk of miscarriage; thus, screening biomarkers are commonly used before undergoing invasive procedures. In our study...

Descripción completa

Detalles Bibliográficos
Autores principales: Buczyńska, Angelika, Sidorkiewicz, Iwona, Ławicki, Sławomir, Krętowski, Adam Jacek, Zbucka-Krętowska, Monika
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8198847/
https://www.ncbi.nlm.nih.gov/pubmed/34071365
http://dx.doi.org/10.3390/jcm10112382

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8198847/
https://www.ncbi.nlm.nih.gov/pubmed/34071365
http://dx.doi.org/10.3390/jcm10112382

Ejemplares similares